Global Polio Vaccine Market Growth 2025-2031

The global Polio Vaccine market size is predicted to grow from US$ 753 million in 2025 to US$ 973 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

LP Information, Inc. (LPI) ' newest research report, the “Polio Vaccine Industry Forecast” looks at past sales and reviews total world Polio Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Polio Vaccine sales for 2025 through 2031. With Polio Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polio Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Polio Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polio Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Polio Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polio Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polio Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)

Segmentation by Application:
Public
Private

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Polio Vaccine market?

What factors are driving Polio Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Polio Vaccine market opportunities vary by end market size?

How does Polio Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.